The British NNL developed technology domestic productions a perspective medical radioisotope lead-212

Scientists from National nuclear laboratory United Kingdom (NNL) developed process of productions the country's first medical radioisotope lead-212 (Pb-212). This radioisotope is used in the new medical therapy called by target alpha therapy in which the alpha radiating isotope is combined with protein or an antibody which are specially aimed at cancer cells and destroy them, minimizing damage of healthy fabrics. However application of these methods of treatment restrains global deficiency of radioisotopes. Health care and nuclear medicine - one of four areas activity...